[Treatment of nonmetastatic CRPC : Androgen receptor inhibition as new treatment standard in nonmetastatic castration-resistant prostate cancer with high risk of metastasis].

Saved in:
Bibliographic Details
Title: [Treatment of nonmetastatic CRPC : Androgen receptor inhibition as new treatment standard in nonmetastatic castration-resistant prostate cancer with high risk of metastasis].
Transliterated Title: Therapie des nicht-fernmetastasierten CRPC : Androgenrezeptorinhibition als neuer Therapiestandard beim nicht-fernmetastasierten kastrationsresistenten Prostatakarzinom mit hohem Metastasierungsrisiko.
Authors: Hadaschik B; Urologische Universitätsklinik, Universitätsklinikum Essen, Hufelandstraße 55, 45147, Essen, Deutschland. boris.hadaschik@uk-essen.de., Hellmis E; Urologicum Duisburg, Duisburg, Deutschland.
Source: Der Urologe. Ausg. A [Urologe A] 2021 Jun; Vol. 60 (6), pp. 753-759. Date of Electronic Publication: 2021 Feb 11.
Publication Type: Journal Article; Review
Journal Info: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 1304110 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1433-0563 (Electronic) Linking ISSN: 03402592 NLM ISO Abbreviation: Urologe A Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1433-0563
DOI:10.1007/s00120-021-01473-0